- 081New productsSource · Medical Device Network
BD launches Elyra thulium fiber laser system for kidney stone care
BD launched the Elyra thulium fiber laser system in the US for kidney stone treatment and urologic procedures. The system expands BD's portfolio in the urology market, offering an advanced laser technology for minimally invasive stone management.
- 082New productsSource · Medical Device Network
Hydrophilic coatings: choice, flexibility and supply chain resilience
Formacoat has introduced a hydrophilic coating platform designed to provide OEMs with an independent supply option for device surface treatments. The solution addresses supply chain resilience and manufacturing flexibility for medical device makers who apply coatings to catheters, guidewires, and similar products.
- 083RegulationSource · Medical Device Network
Adagio Medical seeks FDA PMA for ventricular ablation system
Adagio Medical submitted a premarket approval application to the FDA for its vCLAS ventricular ablation system, a catheter-based device designed for treatment of ventricular arrhythmias. The PMA filing represents a key regulatory milestone for the company's ablation technology.
- 084TechnologySource · Healthcare IT News
Hong Kong moves to mandate digital antimicrobial records
Hong Kong is implementing an electronic antimicrobial transaction record platform to support upcoming legislation requiring licensed pharmaceutical traders and pharmacies to digitally record antimicrobial prescriptions and dispensing. The initiative, confirmed by the Acting Secretary for Health, addresses regulatory compliance for tracking antimicrobial use across the healthcare supply chain.
- 085New productsSource · Mobi Health News
Elon Musk's Neuralink reveals new robotic system for BCI brain implant surgeries
Neuralink announced a next-generation robotic system designed to perform key procedural steps during implantation of its brain-computer interface devices. The robot represents an advance in surgical automation for BCI procedures, targeting the neurosurgical and implantable device market.
- 086TechnologySource · Healthcare IT News
InterSystems Automates Bi-Directional Data Exchange between Epic Payer Platform and Health Plan Workflows
InterSystems announced automation of bi-directional data exchange between Epic's payer platform and health plan workflows. The integration streamlines data flow between payer systems and Epic's platform, reducing manual data handling and improving interoperability between health plan operations and Epic infrastructure. The move addresses connectivity gaps in the payer-provider IT landscape.
- 087TechnologySource · Medical Device Network
Podcast: Flexible instruments for minimally invasive treatment – what OEMs need to know
Alleima Medical's Global Product Manager Tom Schmid discusses advances in flexible instruments for minimally invasive treatment in a podcast episode aimed at OEMs. The discussion covers material and design innovations relevant to manufacturers developing flexible surgical and diagnostic tools.
- 088MarketSource · Medical Device Network
Neurosoft Bioelectronics raises $7.5m to progress BCI development
Neurosoft Bioelectronics has raised $7.5 million in funding to support clinical trials and US commercialisation of its brain-computer interface (BCI) technology. The capital will advance the company's development and regulatory pathway for its neurotechnology platform.
- 089MarketSource · Medical Device Network
Medtronic to acquire SPR Therapeutics for $650m
Medtronic announced an agreement to acquire SPR Therapeutics for approximately $650 million in upfront cash. The deal expands Medtronic's chronic pain treatment portfolio, adding SPR's neuromodulation and pain-management technologies to the company's existing offerings in that therapeutic area.
- 090New productsSource · Medical Device Network
Jupiter Endovascular’s pulmonary embolectomy system hits primary endpoints in trial
Jupiter Endovascular's Vertex pulmonary embolectomy system met primary endpoints in clinical trials. The device uses transforming fixation technology to improve catheter navigation through the right heart into the pulmonary arteries for treatment of pulmonary embolism.
- 091RegulationSource · Medical Device Network
OncoSil Medical secures TGA approval for pancreatic cancer device
OncoSil Medical received approval from Australia's Therapeutic Goods Administration (TGA) for its OncoSil device, a pancreatic cancer treatment indicated for use with gemcitabine-based chemotherapy in locally advanced pancreatic cancer (LAPC). The clearance expands the device's regulatory footprint in the Asia-Pacific region.
- 092MarketSource · Mobi Health News
Neurosoft Bioelectronics garners $7.5M for brain-computer interface technology
Neurosoft Bioelectronics closed a $7.5 million seed funding round led by Skybound Venture Capital, bringing total funding to over $20 million. The company is developing minimally invasive brain-computer interface technology. The round was oversubscribed and included participation from IAG Capital Partners, Connecticut Innovations, and PL Capital.
- 093RegulationSource · Medical Device Network
FDA approves Guardant Health’s next-generation liquid biopsy panel
The FDA approved Guardant Health's Guardant360 Liquid, a next-generation liquid biopsy panel that expands genomic assessment to a 100-fold wider footprint compared to its predecessor, intended to support cancer treatment decisions.
- 094MarketSource · Healthcare IT News
Qualtrics eyes a data engine to predict the experiences patients want
Qualtrics completed its $6.75 billion acquisition of Press Ganey Forsta and plans to expand its human-experience-management platform by leveraging what it describes as the largest HX dataset globally. The company intends to integrate AI capabilities to shift experience management from reactive measurement to predictive analytics across industries, including healthcare applications focused on anticipating patient needs and aligning delivery with consumer expectations.
- 095MarketSource · Medical Device Network
Cagent Vascular raises $41m for dual-modality IVL platform advancement
Cagent Vascular raised $41 million in funding to advance its Serranator SONIC intravascular lithotripsy (IVL) system. The capital will support completion of a pivotal clinical trial and commercial readiness for the dual-modality platform, which combines sonic and mechanical energy to treat calcified lesions in coronary and peripheral vessels.
- 096MarketSource · Medical Device Network
Endologix purchases thrombectomy system from Surmodics
Endologix acquired the Pounce mechanical thrombectomy system from Surmodics, expanding its vascular intervention product portfolio. The acquisition adds a minimally invasive clot-removal device to Endologix's existing vascular and endovascular offerings.
- 097RegulationSource · Medical Device Network
Sunrise Group secures FDA clearance for home sleep test
Sunrise Group obtained FDA clearance for Sunrise Air, a rechargeable at-home sleep diagnostic device. The clearance permits the company to market and distribute the device in the US for home-based sleep testing.
- 098New productsSource · Fierce Healthcare
Labcorp joins lab results personalization push with ‘MyLabcorp’ AI app
Labcorp launched MyLabcorp, an AI-powered app designed to help patients understand and navigate their laboratory test results. The move reflects broader industry momentum toward AI-driven patient engagement tools in clinical laboratory services, positioning Labcorp to compete in the growing market for personalized lab result interpretation platforms.
- 099New productsSource · Medical Design & Outsourcing
Dukane welding tech supports wearable diabetes device
Dukane has deployed its servo ultrasonic welding technology with Melt-Match® to support production of critical components for a wearable glucose monitoring device used in diabetes management. The technology enables precision assembly of the medical device, which is manufactured by a leading medical technology company.
- 100MarketSource · Mobi Health News
Alcidion buys Telstra Health patient flow assets and more briefs
Alcidion, an ASX-listed vendor, has agreed to acquire Telstra Health's Kyra patient flow solutions suite, which includes Kyra Patient Flow Manager, Kyra Queue Manager, and Kyra IQ. The acquisition expands Alcidion's enterprise patient flow software across Australia. Kyra products support inpatient and outpatient workflows including bed management, patient check-ins, wayfinding, referral management, triage, billing, data consolidation, and operational reporting.
- 101RegulationSource · Mobi Health News
UK clears South Korean BP ring and more briefs
South Korean company Sky Labs received UK regulatory clearance from the Medicines and Healthcare products Regulatory Agency for its CART PLATFORM, a blood pressure monitoring system comprising a wearable ring, mobile application, server, and web viewer for clinical use.
- 102MarketSource · Medical Design & Outsourcing
AP Technologies acquires Blueacre Technology
AP Technologies acquired Blueacre Technology, an Ireland-based specialist in laser micromachining and nitinol processing for medical devices. The deal establishes AP Technologies' first European operation and expands its catheter platform to include laser-processed metallic components for minimally invasive surgical devices.
- 103MarketSource · Medical Design & Outsourcing
Robotics expert Brian Miller on product development, AI and what he learned at Intuitive
Brian Miller, former executive vice president and chief digital officer at Intuitive Surgical, has joined Sovato as CEO. Miller spent a long career at Intuitive, the leading surgical robotics company, and is now leading Sovato's efforts to scale telesurgery platforms. The move reflects executive-level shifts in the surgical robotics and digital surgery sector.
- 104TechnologySource · Healthcare IT News
Roundup: More identity verification tech for digital health exchanges
Technology vendors including Verato are releasing identity verification solutions designed to secure provider and patient access to digital health exchanges, improve interoperability, and reduce fraud. The tools address traditional challenges in identity matching across fragmented hospital and insurance databases.
- 105New productsSource · Medical Design & Outsourcing
The new J&J Shockwave C2 Aero IVL device is faster and more flexible
Johnson & Johnson MedTech launched the Shockwave C2 Aero, a fifth-generation intravascular lithotripsy catheter for coronary calcification treatment. The device received FDA approval in June 2025 and rolled out in the United States and Japan in May 2026. The C2 Aero is designed to handle complex calcification patterns and reduce treatment duration compared to earlier generations.
- 106MarketSource · Mobi Health News
Commure raises $70M, boosting post-money valuation to $7B
Commure, an AI-enabled healthcare software company, raised $70 million in Series D funding led by General Catalyst, bringing total funding to $750 million and post-money valuation to $7 billion. The company and its subsidiary Athelas provide AI tools to help healthcare providers with administrative workflows.
- 107RegulationSource · Medical Device Network
Boston Scientific’s coronary IVL catheter hits primary endpoints in trial
Boston Scientific's Seismiq 4CE Coronary catheter, which uses intravascular lithotripsy (IVL) technology, met primary endpoints in its IDE trial. The company plans to file with the FDA based on these results to seek clearance for the device used in coronary interventions.
- 108TechnologySource · MedCity News
The Future of Healthcare Screenings: The Power of Vocal Biomarkers
Vocal biomarker analysis enables multi-condition screening from a 40-second voice sample without laboratory visits or physical examination. The approach uses voice analysis software to detect disease signatures, offering a non-invasive, scalable alternative to traditional diagnostic methods. Applications span respiratory, neurological, and cardiovascular conditions.
- 109New productsSource · Medical Device Network
Philips introduces SmartIQ AI software for coronary imaging advancement
Philips has launched SmartIQ, an AI software tool designed to optimize coronary imaging by balancing image quality with radiation dose reduction. The tool addresses a key clinical trade-off in cardiac imaging procedures, targeting vendors and operators seeking to improve workflow efficiency and patient safety in interventional cardiology settings.
- 110RegulationSource · Medical Device Network
EmStop begins CAPTURE-2 trial of embolic protection system
EmStop has initiated the CAPTURE-2 IDE clinical trial to evaluate its embolic protection system in transcatheter aortic valve replacement (TAVR) procedures. The trial marks a key regulatory milestone in the development pathway for the device, which is designed to capture emboli during valve replacement interventions.
- 111MarketSource · Medical Device Network
Boston Scientific invests $1.5bn for equity stake in MiRus
Boston Scientific announced a $1.5 billion investment to acquire a 34% equity stake in MiRus, a developer of implants and procedural solutions. The investment underscores Boston Scientific's strategy to expand its portfolio in implantable devices and minimally invasive procedural technologies.
- 112TechnologySource · MedCity News
ChatGPT Wants to Improve Your Health — ChatCPR Might Actually Save Your Life
Researchers at UC San Diego, Johns Hopkins, and UPMC developed ChatCPR, an AI-powered coaching tool that guides bystanders through cardiopulmonary resuscitation and outperformed human 911 dispatchers in preliminary testing. The team released the tool as open-source software, targeting deployment by emergency-response organizations and commercial partners seeking to improve real-time dispatch guidance.
- 113MarketSource · Healthcare IT News
Epic gains ground as acute care EHR purchasing slows
Acute care electronic health record purchasing activity declined sharply in 2025 as health systems deferred major platform decisions due to economic pressure, policy uncertainty, and increased investment in AI technologies. Epic expanded its market share during the slowdown in overall EHR procurement.
- 114TechnologySource · Healthcare IT News
Virtual platform offers a valuable lifeline for rural primary care patients
A rural Indiana physician has developed a virtual care platform to address gaps in primary care access for patients in underserved areas. The platform enables remote consultations for acute conditions like urinary tract infections, reducing unnecessary emergency department visits and lowering patient costs. The initiative targets the persistent challenge of after-hours and weekend care availability in rural communities.
- 115MarketSource · Medical Device Network
Artivion strengthens aortic arch portfolio with $135m Endospan acquisition
Artivion has completed a $135 million acquisition of Endospan following US regulatory approval of Nexus, an endovascular device for aortic arch syndrome treatment. The deal, structured under a 2019 agreement, expands Artivion's portfolio in the aortic intervention space and adds Endospan's technology platform to its surgical and interventional cardiology offerings.
- 116New productsSource · Medical Design & Outsourcing
Medtronic launches five-year post-approval study for Altaviva, a 44 mm neurostimulator
Medtronic has enrolled the first patient in ENDURANCE, a five-year post-approval study for Altaviva, its tibial neurostimulator approved in September. The miniaturized implant (43.7 × 15.7 × 4.5 mm) recently won a 2026 Edison Award. The study will track long-term safety and efficacy outcomes in patients receiving the device for chronic pain management.
- 117MarketSource · Medical Device Network
Embecta acquires Owen Mumford for $172.6m
Embecta completed its acquisition of UK-based Owen Mumford Holdings for $172.6 million. Owen Mumford is a medical device manufacturer whose product portfolio spans injection devices, diagnostic sampling systems, and drug delivery solutions. The deal expands Embecta's capabilities in patient-centric device design and drug delivery platforms.
- 118RegulationSource · Medical Device Network
Valar Labs hits US first with breakthrough designation for AI bladder cancer test
Valar Labs received FDA Breakthrough Device designation for Vesta Bladder Risk Stratify Dx, an AI-powered diagnostic tool that analyzes stained pathology slides to generate risk assessments for bladder cancer patients. The designation is the company's first in the US market.
- 119New productsSource · Medical Device Network
PainTEQ announces US launch of SI joint implant
PainTEQ announced the US commercial launch of TRAQ, an implant designed for posterior sacroiliac joint fusion. The product launch expands the company's portfolio in the spinal fusion and orthopedic implant market.
- 120TechnologySource · MedCity News
The Hidden Cost of Slow Cyber Remediation in Healthcare
Delayed remediation and slow patch application in healthcare organizations have become critical indicators of leadership priorities and operational risk. The article examines how latency in security fixes directly impacts organizational vulnerabilities and cost of incident response in medical settings.